{"name":"Reprieve Cardiovascular, Inc","slug":"reprieve-cardiovascular-inc","ticker":"","exchange":"","domain":"","description":"Reprieve Cardiovascular, Inc is a specialty pharmaceutical company focused on developing and commercializing innovative cardiovascular treatments. The company has three marketed drugs, primarily diuretics, aimed at addressing unmet needs in the treatment of heart failure and related conditions.","hq":"","founded":0,"employees":"N/A","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":2,"colorKey":"oncology","drugs":[{"name":"Diuretic","genericName":"Diuretic","slug":"diuretic","indication":"Bloating relief","status":"marketed"},{"name":"furosemide infusion","genericName":"furosemide infusion","slug":"furosemide-infusion","indication":"Other","status":"marketed"}]}],"pipeline":[{"name":"Diuretic","genericName":"Diuretic","slug":"diuretic","phase":"marketed","mechanism":"Small molecule","indications":["Bloating relief","Swelling relief","Joint stiffness relief","Weight gain relief","Fatigue relief"],"catalyst":""},{"name":"furosemide infusion","genericName":"furosemide infusion","slug":"furosemide-infusion","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMikgFBVV95cUxPMnppRkZqaVlfU1BNSld5UjI2SFh5T2Nyd2Z4cGNjYXhvX2p4NUhoNXNqMnNnRHEwWk1tYlJEMFFmWGVwZ3JNTHM3NHRNVl90MjhaNURnS0pfVkE5UjdiOUIzX3lCSEVuUHNUWU9PT3R4MmhHWkl5UXc0SDhudGlDeWNiSnFIX28wbXJUVUdTREtSQQ?oc=5","date":"2025-12-11","type":"pipeline","source":"American Heart Association Journals","summary":"Baseline ECG and Cardiovascular Outcomes in People With HIV : Insights From REPRIEVE - American Heart Association Journals","headline":"Baseline ECG and Cardiovascular Outcomes in People With HIV : Insights From REPRIEVE","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi0AFBVV95cUxNTGI3b2x2TFVYR0RfNHM3QlNVWWVEZUJlQ1d4QUZBMVc4akw3Szd4SENud3JMb3o1Wmsxdnl5QnU4U0d5dGNxRjJQc084d09FVVU0YV9wYkV5TDBNMXNXdl9oN2pVckVqRFJ3OFZkcDFnYktiRWg3UVVtWDFMLVdDX1AxaGl1YTU0X3FKRDdTTDhRemw3TlUtZVMyempLNUNKb3RLelU0eDdpcjZoX081WmptcjlTamxMbXp5THB6MzZWM0NFRE8xejBmejdISnhP?oc=5","date":"2025-08-14","type":"trial","source":"BioSpace","summary":"Reprieve Cardiovascular Secures $61 Million Financing and Enrolls First Patient in Pivotal Study - BioSpace","headline":"Reprieve Cardiovascular Secures $61 Million Financing and Enrolls First Patient in Pivotal Study","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilAFBVV95cUxNbUJPSGxQYm9oWHdkVk1TYVU3MzJnVmRES09QOGVGVm8wNHZEakJGVVNOWHNDMDl0cXNsZkRXcW5wYUd1NkstZFMwMG04RzNfQVYtS3JtQmpYNEdPM1RvbFh2VDUxQy0yRUIzQWV6V2FVaWNPd1MxUktnRXktSFBSMFZ5ajlneGRYTUxWVHFlaGFuWWp3?oc=5","date":"2025-03-12","type":"pipeline","source":"European AIDS Treatment Group","summary":"ACTG presents important findings from REPRIEVE at CROI 2025 - European AIDS Treatment Group","headline":"ACTG presents important findings from REPRIEVE at CROI 2025","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqAJBVV95cUxPRHp1dlYtXzRod255Q2t6QnEyMG9UaWFoVENMSFJmUnZOQU5tbUhBY3RtM1dvMkU5WFdxaTZWV0tYeDFJM1ozQWNTamJ6bVlVa3A5NVVPT2NfZXV2ZVlJSUlDcGFlMkcySy05UTEyZkhrOEdkWkZoVjdCU2ZPbTN0VGdsTDdDamZJNUpCMEF3Y3FnNGZ5VVdpX0V5Njl4d2VSbFFGRXUtWEhuaUhrYWpRYnBaSENKcEx6QU9lYXpqSVJ3cVREVDRkb2ZvTThQSnc1YmlYNWFRY09jOHZJbl9RanYwSE95NF9aTDMxZDhDQWcyZ29ST2hXRnM3a0hja3VNSnhFSTdvTkZDNjZtNkFvbUhpT0k0cFpsWmZSVzNEbE1qZWJRa1BaXw?oc=5","date":"2025-02-11","type":"regulatory","source":"BioSpace","summary":"Reprieve Cardiovascular Builds Clinical Momentum with Positive Results from FASTR Pilot Trial and FDA Investigational Device Exemption Approval for Pivotal Trial - BioSpace","headline":"Reprieve Cardiovascular Builds Clinical Momentum with Positive Results from FASTR Pilot Trial and FDA Investigational De","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMirAJBVV95cUxPeDAyZTZFb2R3Y2tSdXVtMlk1OUlmaTVDX18xTkRaXzFmWkQ4ZmJVUFhmQ1h4ZG5Dcl9qN2dXazFOUjBvdEZQajh1V3k4ajBSQV93TUpDYmE4eUk5UmNMUkpfVmhwX0gyWkdXMjdjeDF5M05uLTAyYS1WOEhhU3FHUzB1a0ZoZFNCMk1IbzV2X1pjVG5xVnFzM3BJc1RvTkVJTEh1Y2xlVy1tY2g1YlNURU1qSzVGUjNNaEFBYzNKeUpNcDRoMTFSMFZtRXJRc2dsRmdCcXQ1TS0wa0VVZFdyREVia3BjbG9fXzFERHRWczhYMnN1U3JHRFZpMXhLQkJQTHI2YjNmRkFVVDY0eEhCblMwM09oZE5EZ0w3aXRDWUhNaV9LLWVXY19wU1k?oc=5","date":"2024-10-07","type":"trial","source":"BioSpace","summary":"Reprieve Cardiovascular Completes Enrollment in Randomized Pilot Trial Evaluating First-of-its-Kind Personalized Fluid Management System for Acute Decompensated Heart Failure - BioSpace","headline":"Reprieve Cardiovascular Completes Enrollment in Randomized Pilot Trial Evaluating First-of-its-Kind Personalized Fluid M","sentiment":"negative"},{"url":"https://news.google.com/rss/articles/CBMiwwFBVV95cUxPVVdXYUp5TjVrVEU5aWEtRU85X0RQTnRNZld6MkpMR0IwTTdUTjBKZFlsdEVRSlFzN0ltQ1F2UEEydnM1Y3hVV1lMREdwU2JwUjlGN0lTcDVRaEIyZkJqdC1hQ0lubzNHbHN6bjR2U0gxOER3VHI2MU1EZU1TZ3FlRDJjdlJ4ZlNPS21GSng1YnZ4aWl5R1kwVzR6YTZ1QlRGeGtZZHNxYk4xb2tQOV9Ub2JhN0N1OHg5YlBsZEs3YzdnSDA?oc=5","date":"2024-05-02","type":"regulatory","source":"dicardiology.com","summary":"New Study Published in JACC: Heart Failure Reveals that Despite Significant Efforts to Improve Acute Heart Failure Treatment Over the Past 20 Years, Management Remains Unchanged - dicardiology.com","headline":"New Study Published in JACC: Heart Failure Reveals that Despite Significant Efforts to Improve Acute Heart Failure Treat","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwwFBVV95cUxQeG1sNU9fX0R0bXRxWmxuZmpNZkdPWTlVVjlOVndaM28xSXJad0JkQnZJQUp5NXNsbHBjS2dudjNlVG45c21CM1hMenJuMGd4MFZ4cUxWMVNxYXdlRTNKcVVkR3ZMQ2NzWVNqc1A3elpaOFpqNUFMem9oUEgxOUVSX2xZZU5CakhIeEZKQVRqMDVCRTZodWZLbWFTSlJ3QndFaEhmX1lJeTFQQ0UzU2JBbDZNdkwwbHZJNW9lenRteHVXYnM?oc=5","date":"2023-04-13","type":"trial","source":"dicardiology.com","summary":"Daily Statin Reduces the Risk of Cardiovascular Disease in People Living with HIV, Large NIH Study Finds - dicardiology.com","headline":"Daily Statin Reduces the Risk of Cardiovascular Disease in People Living with HIV, Large NIH Study Finds","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiekFVX3lxTE1QZWdaUkY5NU1HUDhtclhldnA0N0dYQnBxWFhRTjlxOHlMaEpIeGpUUVVNNVZULS1UTkI3WWhmWm55c0FQM0FEejlzemtUQm1ULVFjNUhoeEJMNzhPMmNlWi1BcU5oaGRrLUY3clAzLW5IRTNheUpIbDZn?oc=5","date":"2021-04-29","type":"pipeline","source":"BioSpace","summary":"BioVentrix Names Jim Dillon President and CEO - BioSpace","headline":"BioVentrix Names Jim Dillon President and CEO","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimAFBVV95cUxNTmNoaXVoNHc0ZmtEQ085MGJ6cXI1STlabTN4cHhJbU9sbDM1TW9NeXVxZUdRcy14OWRuQ2dRcHRnSGVLSDdmQWt5aXJDTWJBSnBMVUZhdlVjWC1JMV93bElfeG90Q1FsTXA4LU9hRmprRnRFaFJidVNYbnlsejBiNmwzUFoxQVRZRnBwMTdadEs4b0cwWUtrWQ?oc=5","date":"2019-05-28","type":"trial","source":"MassDevice","summary":"Reprieve Cardio touts Reprieve-Guided diuretic therapy study data - MassDevice","headline":"Reprieve Cardio touts Reprieve-Guided diuretic therapy study data","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikAFBVV95cUxQLTFscndib3I1SS1IWHh6SVcwdURta1lLeHE4N2dFRW1CM0FRMUdaVkc3WkdKc1JtcGFmbDNjbVl4X3VMVHRObzlEc2xoc2tTZFFSbDJlX1JMVkJ1NDAxeWpqUkdIeHR3WVZuMmEtcmZqS1c5ZXZMdU1Lb2pKeEJfUV9VZm0zb3VmeU9JOVphYWc?oc=5","date":"2018-12-20","type":"trial","source":"MassDevice","summary":"Reprieve Cardiovascular touts early ADHF therapy study data - MassDevice","headline":"Reprieve Cardiovascular touts early ADHF therapy study data","sentiment":"neutral"}],"patents":[],"drugCount":2,"phaseCounts":{"marketed":2},"enrichmentLevel":2,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}